Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

      June 8, 2023

      Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

      June 7, 2023

      Biotechs face challenges as the industry’s annual bash returns to Boston

      June 5, 2023

      The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

      June 5, 2023

      China reaching for biotech breakthroughs in space

      June 2, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»Optical ‘tweezer’ enables fast, low-cost screening of bacteria and cancer cells
    Bio Technology

    Optical ‘tweezer’ enables fast, low-cost screening of bacteria and cancer cells

    yourbiotechBy yourbiotechDecember 30, 2022Updated:December 30, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences (CAS) have proposed a new technology, called optical tweezer-assisted pool-screening and single-cell isolation (OPSI) system, which achieves 99.7% purity of sorting target cells, with all done in real-time.

    The study was published in Lab on a Chip on Nov. 29.

    Current cell-sorting methods cannot effectively sort cells of various sizes while maintaining their viability for future testing. Compared with the currently used methods, the OPSI technology reduces the cost and resources consumed. It also saves time, which is of utmost importance when dealing with abnormal cells or pathogens.

    Imagine a regular pair of tweezers: they’re used for grabbing small, often unwanted objects such as a stray hair or splinter. An optical tweezer uses this same idea, but instead of a metal object, it is a highly focused laser that can hold, manipulate, and move the desired object, which in this case are the target cells.

    Being able to pick or “tweeze” out certain cells comes in handy when dealing with cancerous or other target cells and pathogens that need to be further studied. This optical tweezer is used on a cell pool confined in a microfluidics chip, which is usually a glass slide with microchannels molded into the material. Once the target cell is identified (usually through targeted fluorescence, Raman imaging, or bright-field microscopy), it can easily be packaged in a microdroplet and exported in a “one-cell one-tube” manner for later amplification and analysis.

    “Real-time image-based sorting of target cells in a precisely indexed manner is desirable for sequencing or cultivating individual human or microbial cells directly from clinical or environmental samples, however, the versatility of existing methods is limited as they are usually not broadly applicable to all cell sizes,” said Xu Teng, paper-first author from Single-Cell Center of QIBEBT.

    An artificial test mixture of green-fluorescent protein (GFP) E. coli, non-GFP E. coli, and yeast were loaded onto the chip in a 1:1:1 ratio, and quickly the GFP bacteria and yeast were separated.

    To further test the efficacy of this method, a mixture using only 0.1% of the GFP E. coli was used, and the fluorescent cells were easily detected and isolated amidst a mixture of other cells of varying sizes.

    “The precise isolation and broad spectrum of cell sizes that can be manipulated using OPSI not only allows for easy target cell acquisition but can also greatly reduce the volume required to study the sample,” said co-first author Li Yuandong, an engineer at Single-Cell Center of QIBEBT. Isolating and capturing the target cells in microdroplets also maintains a high quality of the cell’s information, allowing for more genes to be detected while minimizing the resources needed. “This is of particular importance when it comes to rare or small samples which can easily be consumed entirely in one test which may not even maintain the quality of the sample.”

    “Taking advantage of the wide-field imaging rather than detecting single cells one by one in a flowing stream, the recognition of target cell can be very fast,” said co-corresponding author Prof. Xu Jian, from Single-Cell Center of QIBEBT. “OPSI also achieves >99.7% target-cell sorting purity and 10-fold elevated speed of 10~20 cells/min.”

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleStudy shows the de novo origination of functional microproteins
    Next Article Janux Therapeutics Submits IND Application for JANX008
    yourbiotech
    • Website

    Related Posts

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023

    The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

    June 5, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.